Einstein/Montefiore Department of Medicine

10-22-09: Paradigm Shift: Reducing Dependence on Serum Creatinine in AKI

Paradigm Shift: Reducing Dependence on Serum Creatinine in Acute Kidney Injury

Einstein-Montefiore Department of Medicine Grand Rounds

Thursday, October 22, 2009

8:00 am
First Floor Lecture Hall, Forchheimer/Einstein

12:15 PM,
Cherkasky Auditorium, Moses/Montefiore


Chirag Parikh, MD
Associate Professor of Medicine, Section of Nephrology
Yale University School of Medicine
Associate Professor, Clinical Epidemiology Research Center
VA Connecticut Health Care System 

Dr. Chirag Parikh conducts an active patient-oriented research program investigating translational and epidemiological aspects of Acute Kidney Injury (AKI) and other kidney related disorders. His major research interest is developing novel biomarkers of AKI. He is the PI of the NIH sponsored TRIBE-AKI consortium that is conducting two large studies for validating novel urinary biomarkers in AKI. He has authored more than 75 peer-reviewed papers, 10 book chapters, and has given more than 25 invited lectures at scientific meetings and academic institutions around the world.

Dr. Parikh is board certified in Internal Medicine and Nephrology. He has received several awards, such as National Junior Physician Investigator Award from the American Federation of Medical Research, and the “Outstanding Investigator” award at the Western Regional meeting of American Federation of Medical Research (AFMR).

Dr. Parikh received his MD degree from Mumbai, India, in 1996. His post-graduate training involves a residency in Internal Medicine at Nassau University and SUNY at Stony Brook, NY, and a Fellowship in Nephrology and Hypertension at the University of Colorado Health Sciences Center, Denver, CO. He has also completed a PhD in Clinical Investigation and Translational Research at University of Colorado Health Sciences Center, Denver, CO, 2003.

This grand rounds is hosted by the Division of Nephrology.


After attending this activity, participants will be able to:

  1. Highlight limitations of serum creatinine
  2. Describe novel kidney injury biomarkers currently in development
  3. Discuss concepts related to biomarker development


Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Contact Us

Department of Medicine
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
Belfer Building - Room 1008
1300 Morris Park Avenue
Bronx, NY 10461 (directions)

Physicians and Patients:
866-MED-TALK (866-633-8255)

Internal Medicine Residency Program:

Administrative Questions:
Fax: 718-430-8659

Click here to log in